Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001) [Phase 3]
Phase 3 trial comparing mometasone furoate aqueous nasal spray to placebo and Flonase in seasonal allergic rhinitis; study completed with re…
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161) [Phase 3]
A Phase 3 dose-ranging trial of mometasone furoate nasal spray in children aged 6-11 with seasonal allergic rhinitis has completed; results …
-
FDA approval · 2019-08-09FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC, marking an additional regulatory action for the product.
-
FDA approval · 2019-08-09FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013) [Phase 3]
Phase 3 trial comparing mometasone furoate (SCH 032088) with beclomethasone dipropionate or placebo in seasonal allergic rhinitis; results c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145) [Phase 3]
Phase 3 trial assessing safety and efficacy of mometasone furoate nasal spray with loratadine versus placebo in seasonal allergic rhinitis; …
-
CLINICAL_TRIALS trial_result · 2019-07-18Clinical Trial Update: Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280) [Phase 4]
Phase 4 trial comparing Nasonex (mometasone furoate) nasal spray to placebo in participants with seasonal allergic rhinitis and concurrent a…
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Drug Utilization Study for Pirinase Hayfever Relief
A completed clinical trial update for Pirinase Hayfever Relief evaluating drug utilization in seasonal allergic rhinitis; results posted in …
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis [Phase 3]
Phase 3 clinical trial evaluating sublingual immunotherapy for seasonal allergic rhinitis and investigating underlying immunological mechani…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 clinical trial update for ACT-129968 in adults with seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm) [Phase 2]
This Phase 2, five-arm PK/PD and steady-state efficacy trial evaluated bilastine versus placebo in seasonal allergic rhinitis with rhinoconj…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR [Phase 2]
Phase 2 trial evaluating the efficacy, safety, and pharmacokinetics of bilastine 10 mg or 20 mg given once or twice daily versus placebo for…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms [NA]
The study reports on the completed clinical trial evaluating the nasal gel Nascum®-Plus for reducing symptoms of seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Evaluation of Nasal Inflammatory Biomarkers [NA]
A completed clinical trial evaluating nasal inflammatory biomarkers in individuals with Seasonal Allergic Rhinitis.
-
FDA approval · 2018-12-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: DNA Vaccine for Ragweed Allergic Adults [Phase 2]
Phase 2 clinical trial update for a DNA vaccine in adults with seasonal allergic rhinitis has completed.
-
FDA approval · 2018-11-21FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Claritin Chewable Grape and Bubblegum (loratadine) as a new chewable dosage form, expanding t…
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial evaluating efficacy, safety, and tolerability of ACT-129968 in seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Study of GW685698X In Patients With Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial update for GW685698X in patients with seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Study Of Perennial Allergic Rhinitis [Phase 3]
Phase 3 clinical trial update for perennial allergic rhinitis sponsored by GlaxoSmithKline has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 trial results for fixed dose combination GSP 301 nasal spray in seasonal allergic rhinitis have been completed with results posted i…
-
FDA approval · 2018-07-31FDA Approved: MONTELUKAST SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original ANDA for montelukast sodium (generic montelukast).
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects [Phase 4]
Phase 4 trial comparing levocetirizine and montelukast against placebo for reducing seasonal allergic rhinitis symptoms in ragweed-sensitive…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen [Phase 2]
Phase 2 trial comparing levocetirizine to placebo for reducing seasonal allergic rhinitis symptoms in ragweed-exposed subjects; results post…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis [Phase 3]
Phase 3 clinical trial evaluating the effectiveness of Bifidobacteria in children with seasonal allergic rhinitis.